Loading...

BioPharma Credit PLC

BPCR.L•LSE
Financial Services
Asset Management
£0.87
£0.002(0.23%)

BioPharma Credit PLC (BPCR.L) Stock Overview

Explore BioPharma Credit PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.6/100

Key Financials

Market Cap982.5M
P/E Ratio8.70
EPS (TTM)$0.10
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$0.88
1 Month$0.89
3 Months$0.90
1 Year Target$0.86

BPCR.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioPharma Credit PLC (BPCR.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.70 and a market capitalization of 982.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;